BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24094286)

  • 1. Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.
    Usui S; Minami Y; Shiozawa T; Iyama S; Satomi K; Sakashita S; Sato Y; Noguchi M
    Lung Cancer; 2013 Dec; 82(3):407-12. PubMed ID: 24094286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival.
    Bréchot JM; Chevret S; Charpentier MC; Appere de Vecchi C; Capron F; Prudent J; Rochemaure J; Chastang C
    Cancer; 1996 Nov; 78(10):2111-8. PubMed ID: 8918404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
    Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
    Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The morphological diversity of small lung adenocarcinoma with mixed subtypes is associated with local invasiveness and prognosis.
    Haruki T; Shomori K; Shiomi T; Taniguchi Y; Nakamura H; Ito H
    Eur J Cardiothorac Surg; 2011 May; 39(5):763-8. PubMed ID: 20864350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
    Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
    Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takenaka A; Nakayama T; Yoneda G
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vascular invasion by tumor in the absence of regional lymph node metastases in patients with locally advanced non-small cell lung cancer].
    Akopov AL; Dvorakovskaia IV
    Vopr Onkol; 2004; 50(4):417-20. PubMed ID: 15605763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2-40-positive lymphatic vessel invasion is not a poor prognostic factor in stage I lung adenocarcinoma.
    Shimizu K; Funai K; Sugimura H; Sekihara K; Kawase A; Shiiya N
    Pathol Int; 2013 Apr; 63(4):201-5. PubMed ID: 23692420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
    Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
    Zhang Y; Yan M; He J; Sun J; Sun X
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma.
    Funai K; Sugimura H; Morita T; Shundo Y; Shimizu K; Shiiya N
    Ann Surg Oncol; 2011 Oct; 18(10):2968-72. PubMed ID: 21512862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal?
    Kawase A; Yoshida J; Ishii G; Nakao M; Aokage K; Hishida T; Nishimura M; Nagai K
    Jpn J Clin Oncol; 2012 Mar; 42(3):189-95. PubMed ID: 22210923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.
    Sakao Y; Miyamoto H; Sakuraba M; Oh T; Shiomi K; Sonobe S; Izumi H
    Ann Thorac Surg; 2007 Jan; 83(1):209-14. PubMed ID: 17184664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of lymphatic and blood vessel invasion in oral tongue squamous cell carcinomas.
    Michikawa C; Uzawa N; Kayamori K; Sonoda I; Ohyama Y; Okada N; Yamaguchi A; Amagasa T
    Oral Oncol; 2012 Apr; 48(4):320-4. PubMed ID: 22178206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
    Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive histopathological features of lepidic growth predominant node-negative adenocarcinomas 3-5 cm in size.
    Takahashi Y; Ishii G; Aokage K; Hishida T; Yoshida J; Nagai K
    Lung Cancer; 2013 Feb; 79(2):118-24. PubMed ID: 23177278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PCNA (proliferating cell nuclear antigen) expression in adenocarcinomas < 2 cm of the peripheral lung].
    Koshikawa T; Nakamura S; Kitoh K; Hayashi K; Suyama M; Kunishima K
    Rinsho Byori; 1993 Jun; Suppl 94():113-24. PubMed ID: 8103122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.